The global healthcare industry has shifted toward rapid diagnostics, particularly for infectious diseases. Among these advancements, rapid syphilis testing has emerged as a crucial method in early disease detection and treatment. With syphilis cases on the rise in several regions, medtech companies are focusing on developing highly accurate, accessible, and cost-effective testing solutions. Manufacturers are focusing on developing eco-friendly, biodegradable test kits that reduce medical waste. As regulatory authorities tighten restrictions on plastic usage and hazardous materials in healthcare products, companies are exploring sustainable alternatives for rapid diagnostic devices.




